SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001171843-16-011564
Filing Date
2016-08-08
Accepted
2016-08-08 08:16:02
Documents
47
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q f10q_080816p.htm 10-Q 693826
2 EXHIBIT 31.1 exh_311.htm EX-31.1 8006
3 EXHIBIT 31.2 exh_312.htm EX-31.2 6192
4 EXHIBIT 32.1 exh_321.htm EX-32.1 5697
  Complete submission text file 0001171843-16-011564.txt   2484131

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE prto-20160630.xml EX-101.INS 300722
6 XBRL SCHEMA FILE prto-20160630.xsd EX-101.SCH 29294
7 XBRL CALCULATION FILE prto-20160630_cal.xml EX-101.CAL 26416
8 XBRL DEFINITION FILE prto-20160630_def.xml EX-101.DEF 196112
9 XBRL LABEL FILE prto-20160630_lab.xml EX-101.LAB 190948
10 XBRL PRESENTATION FILE prto-20160630_pre.xml EX-101.PRE 212307
Mailing Address 200 WEST STREET WALTHAM MA 02451
Business Address 200 WEST STREET WALTHAM MA 02451 781-890-0102
PROTEON THERAPEUTICS INC (Filer) CIK: 0001359931 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36694 | Film No.: 161812806
SIC: 2836 Biological Products, (No Diagnostic Substances)